Confirmed! Are You Ready to Trade Biotech?

Your registration for my upcoming special event is now confirmed. Hey there, This is Keith Kohl. And I hope you’re excited. Because you’ve just secured a seat to my EXCLUSIVE biotech trading summit. On May 20 at 3 p.m. EST, you’re going to learn the exact strategy my team and I have been using for the past two years to find HOT biotech trade opportunities. I’m talking sizzling, surface-of-the-sun-level hot. For instance, using the strategy that I’m going to show you… My team and I were able to score a 70% gain on Aquestive Therapeutics in just three weeks! We also used this strategy to find a 29% gain on Viemed Healthcare that also played out in less than a month! Sometimes, the trades are smaller, like this 14% winner on Clovis Oncology (though I’m not going to complain about a 14% gain in just two short weeks). But the opportunities can also be bigger — sometimes much bigger. Take Intra-Cellular Therapies, which handed us a 225% winner... Again, in just two weeks. What I’m going to show you on May 20 at 3 p.m. EST is a way to find these high-impact trade opportunities again and again and again... Sometimes as many as THREE each week! So I hope you’re excited. I know I am. Now, to get you ready for the summit, I’m going to be sending you a few “big-picture content" emails over the next few days. These will lay out the framework of my strategy and help you understand why this strategy is such a powerful way to improve your trading success. So be on the lookout for those. But before I go, I need to ask YOU to do something for ME. I want to make sure you don’t miss any of my emails, especially since this is a one-time event that I would hate for you to miss out on because my email goes to some random folder in your inbox. So here’s what I want you to do (please!): Make sure to drag this email into your main email inbox tab. On Gmail, that’s your “Primary” tab. Please also whitelist this email address. And finally, I want to hear from you: Why do you want to trade biotech? That answer is going to be different for everyone. Some people may just be doing it for fun. Other people may want to trade in order to boost their retirement accounts. What’s your story? I want to hear it. Just click “Reply” to this email and let me know what makes you so excited about my upcoming summit. I promise I’ll read every email. Talk soon, [Keith's Sign off] Keith Kohl Founder, The Catalyst Calendar Summit P.S. It’s very important that you don’t miss any of the broadcast so [click here to add the event to your Google or Outlook Calendar.]( And I highly recommend that you [click here to sign up for SMS text reminders.]( --------------------------------------------------------------- If you no longer wish to receive updates from Catalyst Calendar you [may opt out here.]( Catalyst Calendar, Copyright © 2021, Angel Publishing, LLC., $custom_ap_address. For customer service, please call $custom_ang_csphonenumber. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Angel Publishing and Catalyst Calendar do not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. The publisher, editors, and consultants of Angel Publishing may actively trade in the investments discussed in this newsletter. They may have substantial positions in the securities recommended and may increase or decrease such positions without notice. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by xerography, facsimile, or any other means is illegal and punishable by law.